PER2 rs11187033: Chronotype and Circadian Rhythms
The single nucleotide polymorphism rs11187033 is a genetic variant located within the PER2 gene, a central molecular component of the human circadian timing system. Research associates this variant with subtle individual differences in circadian phase, habitual sleep timing, and chronotype preference. Because evidence for this specific variant is limited and circadian behavior is heavily shaped by light and lifestyle, it acts as a modest statistical influence rather than a direct determinant of sleep habits.
What each genotype means
Typical circadian timing
You carry two copies of the common C allele for this PER2 variant. Research indicates this genotype is associated with a baseline circadian phase and average natural sleep timing. Because the overall scientific evidence linking this single non-coding variant to sleep preference is limited and modulated by many other genetic and environmental factors, carrying CC represents a standard population background.
Carried by approximately 70% to 75% of individuals of European ancestry and is the predominant genotype across global populations.
Slight tendency toward later sleep
You carry one copy of the minor T allele associated with subtle variations in circadian rhythm regulation. Some studies have linked the T allele with a modest shift toward an evening chronotype or later habitual sleep timing, though findings remain preliminary and have limited independent replication. This genetic variation represents only a minor influence compared to environmental factors like daily light exposure, work schedules, and sleep habits.
Carried by roughly 25% of individuals in European populations, but occurs at considerably lower frequencies in African and East Asian ancestries.
Likely later chronotype tendency
You carry two copies of the minor T allele in the PER2 circadian clock gene. In published association studies, carrying two T alleles has been linked to a modest statistical preference for later bedtimes and wake times (evening preference). However, evidence for this specific variant is limited, and sleep-wake cycles remain heavily influenced by personal routines, light exposure, and many other genes.
Found in approximately 2% to 3% of individuals of European ancestry and is extremely rare or absent in many non-European populations.
Genetic Identity and Genomic Location
The variant rs11187033 is a single nucleotide polymorphism mapped to chromosome 2 within the human genome, situated in the region of the PERIOD2 (PER2) gene. It represents a common non-coding nucleotide change (typically characterized by an allele transition involving cytosine and thymine) recorded in the dbSNP repository. Unlike rare, high-impact coding mutations that disrupt primary protein sequences, rs11187033 is categorized as a common trait-associated single nucleotide variant. While it does not alter the fundamental coding sequence of the Period-2 protein, non-coding polymorphisms located in or adjacent to circadian genes frequently serve as regulatory markers. Such variants can potentially influence transcription factor binding affinity, messenger RNA transcript stability, or tissue-specific gene expression levels. However, rs11187033 may also simply track along with neighboring functional variants through genetic linkage disequilibrium within European and admixed ancestral chromosomal segments.
The Biological Function of the PER2 Clock Gene
The PER2 gene encodes the Period Circadian Regulator 2 protein, which forms an essential core arm of the cell-autonomous transcription-translation feedback loop driving daily biological rhythms in humans. In central hypothalamic pacemaker neurons as well as peripheral tissues, the master activators CLOCK and BMAL1 stimulate the expression of PER and CRY genes during the biological day. As the PER2 protein accumulates, it heterodimerizes with CRY proteins, translocates into the cell nucleus, and directly represses its own transcriptional activation, a cycle that takes approximately 24 hours to complete. Beyond core cellular timekeeping, PER2 influences downstream physiological processes such as cyclical core body temperature variations, nocturnal melatonin secretion, hormonal balance, and metabolic cycling. Disruption or subtle pacing alterations in PER2 function can therefore shift an individual's intrinsic circadian period, altering natural sleepiness cues and diurnal rhythm timing.
Current Research and Strength of Evidence
Scientific investigations exploring the genetics of diurnal preference have connected variations in PER2 to chronotype—an individual's natural tendency toward morningness or eveningness—as well as habitual sleep phase. For rs11187033, published genome-wide and candidate association studies suggest a modest correlation with preferred sleep timing and circadian phase adjustments. However, the scientific evidence supporting rs11187033 specifically remains classified as limited. Chronotype is an extensively polygenic trait influenced by thousands of common genetic loci scattered across dozens of biological pathways, alongside major non-genetic drivers. Furthermore, while dramatic, penetrant mutations in PER2 cause rare Mendelian disorders like Familial Advanced Sleep Phase Syndrome, common variants like rs11187033 contribute tiny statistical effect sizes. As a result, rs11187033 cannot independently predict whether a person is definitively a morning lark or a night owl.
Ancestry and Population Distribution
Data from international sequencing programs such as gnomAD and the 1000 Genomes Project demonstrate that alleles at rs11187033 vary significantly in frequency across global biogeographical ancestries. In European populations, the minor allele maintains a frequency of approximately 0.15 (15%), which makes both heterozygous carriers and homozygous reference individuals routine occurrences in genetic screening datasets. Across other populations, such as East Asian, South Asian, African, and Indigenous American cohorts, allele distribution patterns vary due to distinct demographic histories, historical bottlenecks, and genetic drift. Because many early circadian association cohorts predominantly examined individuals of European descent, findings linked to rs11187033 should be generalized across diverse ancestral backgrounds with appropriate scientific caution, as linkage architectures and tagging relationships can change.
Practical Implications and Scientific Context
Discovering your rs11187033 genotype provides an educational glimpse into your underlying circadian biology, but it does not represent a medical diagnosis or a fixed behavioral destiny. Common variations in clock genes like PER2 only explain a minuscule percentage of overall individual variance in sleep patterns. Environmental zeitgebers—most notably daytime sunlight exposure, evening blue light from screens, regular meal timings, shift work, and physical exercise—exert far more potent physical control over the circadian pacemaker than individual common single nucleotide polymorphisms. This variant should never be used to diagnose a sleep disorder such as insomnia or delayed sleep-wake phase disorder. Anyone struggling with persistent daytime fatigue, sleep fragmentation, or disrupted rest schedules should seek personalized guidance from a certified sleep specialist or medical professional.
How common is this variant?
The minor allele at rs11187033 has an estimated frequency of approximately 0.15 (15%) in populations of European ancestry, with variable prevalence across other global ancestries in the gnomAD database.
Frequently asked questions
Does having a specific rs11187033 genotype make me a night owl?
No. While rs11187033 is statistically associated with circadian phase and sleep timing preference in research cohorts, human chronotype is shaped by thousands of genetic loci working together. A single common variant exerts an extremely small influence and cannot determine your daily sleep-wake cycle by itself.
Is the rs11187033 variant linked to sleep disorders like insomnia?
Current scientific literature does not support rs11187033 as a direct, causative marker for insomnia or other clinical sleep disorders. Although severe mutations in PER2 can cause rare familial sleep conditions, common variants like rs11187033 are classified as mild trait markers rather than clinical disease determinants.
Can I overcome my genetic chronotype tendency?
Yes. Environmental signals, particularly your daily exposure to natural morning light and avoidance of bright artificial light at night, play a far larger role in entraining your master biological clock than individual genetic variations. Maintaining consistent bedtime routines and sleep hygiene can effectively adjust your sleep phase regardless of genotype.
Where is rs11187033 located in my DNA?
The rs11187033 polymorphism is located on human chromosome 2 within the PER2 (Period Circadian Regulator 2) gene region. PER2 encodes a central regulatory protein responsible for governing 24-hour physiological rhythms in human cells.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11187033?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29